Search
Patexia Research
Case number 1:23-cv-01221

Orion Corporation et al v. Hetero USA Inc. et al > Documents

Date Field Doc. No.Description (Pages)
Jun 18, 2024 43 NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions Pursuant to the District of Delaware's Default Standard for Discovery - filed by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation.(Fahnestock, Derek) (Entered: 06/18/2024) (4)
Jun 5, 2024 42 NOTICE of SERVICE of Defendant's Responses and Objections to Plaintiffs' First Interrogatories and First Requests for Production by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc. (Cramer, Kristen) (Entered: 06/05/2024) (3)
Jun 3, 2024 41 NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Defendants' First Set of Requests for Production of Documents and Things, and (2) Plaintiffs' Responses and Objections to Defendants' First Set of Interrogatories (Nos. 1-9) - filed by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation.(Fahnestock, Derek) (Entered: 06/03/2024) (4)
May 3, 2024 40 NOTICE of SERVICE of Document Production pursuant to Paragraph 4(b) of the Default Standard and Paragraph 1(c) of the Scheduling Order (D.I. 31) by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc. (Cramer, Kristen) (Entered: 05/03/2024) (3)
Apr 5, 2024 39 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Defendants Hetero USA Inc., Hetero Labs Ltd., Unit-V, and Hetero Labs Ltd. and (2) Plaintiffs' First Set of Requests for Production to Defendants Hetero USA Inc., Hetero Labs Ltd., Unit-V, and Hetero Labs Ltd. - filed by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation.(Fahnestock, Derek) (Entered: 04/05/2024) (4)
Apr 4, 2024 38 SO ORDERED, re 35 Stipulated Protective Order. Signed by Judge Jennifer L. Hall on 4/4/2024. (ceg) (Entered: 04/04/2024) (24)
Apr 3, 2024 37 NOTICE of SERVICE of Defendants' (1) Rule 26 Initial Disclosures, (2) Paragraph 3 Initial Disclosures, (3) First Set of Requests for Documents and Things, and (4) First Set of Interrogatories by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc. (Cramer, Kristen) (Entered: 04/03/2024) (3)
Apr 3, 2024 36 NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery and (2) Plaintiffs' Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure - filed by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation.(Fahnestock, Derek) (Entered: 04/03/2024) (4)
Apr 2, 2024 35 PROPOSED Stipulated Protective Order, by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation. (Fahnestock, Derek) Modified on 4/2/2024 (ceg). (Entered: 04/02/2024) (24)
Mar 27, 2024 34 NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patents - filed by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation.(Fahnestock, Derek) (Entered: 03/27/2024) (4)
Mar 26, 2024 33 SO ORDERED, re 32 Joint Stipulation and Order to Extend Time to submit proposed Protective Order and make Initial Disclosures to 4/3/2024. Signed by Judge Jennifer L. Hall on 3/26/2024. (ceg) (Entered: 03/26/2024) (2)
Mar 26, 2024 32 Joint STIPULATION TO EXTEND TIME to submit proposed Protective Order and make Initial Disclosures to 4/3/2024 - filed by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc.. (Cramer, Kristen) (Entered: 03/26/2024) (2)
Mar 12, 2024 31 SCHEDULING ORDER: Joinder of Parties due by 11/15/2024. Amended Pleadings due by 11/15/2024. Fact Discovery completed by 5/30/2025. Expert Discovery due by 12/19/2025. Joint Claim Construction Chart due 10/22/2024. The Court will hold a Telephone Conference on 10/24/2024 at 10:00 AM to discuss Claim Construction. Joint Claim Construction Brief due by 2/11/2025. A Markman Hearing is set for 3/28/2025 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Interim Status Report due by 5/2/2025. Proposed Pretrial Order due by 4/29/2026. A Pretrial Conference is set for 5/6/2026 at 03:00 PM in Courtroom 6D before Judge Jennifer L. Hall. A 4-day Bench Trial is set for 5/11/2026 at 09:30 AM in Courtroom 6D before Judge Jennifer L. Hall. (*See Order for details). Signed by Judge Jennifer L. Hall on 3/12/2024. (ceg) (Entered: 03/12/2024) (15)
Mar 12, 2024 N/A Minute Entry for proceedings held before Judge Jennifer L. Hall - Scheduling Conference held on 3/12/2024. (Court Reporter: Stacy Ingram.) (twk) (Entered: 03/12/2024) (0)
Mar 8, 2024 30 ORAL ORDER Setting Scheduling Conference: A Scheduling Conference is set for March 12, 2024 at 03:00 PM in Courtroom 6D before Judge Jennifer L. Hall. Ordered by Judge Jennifer L. Hall on 3/8/2024. (ceg) (Entered: 03/08/2024) (0)
Mar 5, 2024 29 Letter to The Honorable Jennifer L. Hall from Derek J. Fahnestock regarding Proposed Scheduling Order. (Fahnestock, Derek) Modified on 3/5/2024 (ceg). (Entered: 03/05/2024) (5)
Mar 5, 2024 28 PROPOSED Scheduling Order, by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation. (Fahnestock, Derek) Modified on 3/5/2024 (ceg). (Entered: 03/05/2024) (15)
Feb 28, 2024 27 SO ORDERED, re 26 Stipulation and Order to Extend Time for the parties to provide a proposed scheduling order and accompanying letter to March 5, 2024. Signed by Judge Jennifer L. Hall on 2/28/2024. (ceg) (Entered: 02/28/2024) (2)
Feb 28, 2024 26 STIPULATION TO EXTEND TIME for the parties to provide a proposed scheduling order and accompanying letter to March 5, 2024 - filed by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation. (Fahnestock, Derek) (Entered: 02/28/2024) (2)
Feb 16, 2024 25 ANSWER to 15 Answer to Complaint, Counterclaim by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation.(Fahnestock, Derek) Modified on 2/20/2024 (ceg). (Entered: 02/16/2024) (13)
Feb 6, 2024 24 NOTICE of Appearance by Kristen Healey Cramer on behalf of Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc. (Cramer, Kristen) (Entered: 02/06/2024) (2)
Jan 31, 2024 N/A Pro Hac Vice Attorney Hayk Snkhchyan for Hetero Labs Ltd.,Hetero Labs Ltd., Unit-V, and Hetero USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 01/31/2024) (0)
Jan 30, 2024 23 ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent", and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Order can be found on Judge Hall's portion of the District Court's website. Ordered by Judge Jennifer L. Hall on 1/30/2024. (ceg) (Entered: 01/30/2024) (0)
Jan 30, 2024 N/A Pro Hac Vice Attorney Timothy P. Heaton for Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, and Hetero USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/30/2024) (0)
Jan 30, 2024 N/A Pro Hac Vice Attorney Michael S. Weinstein for Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, and Hetero USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/30/2024) (0)
Jan 30, 2024 N/A Pro Hac Vice Attorney Charanjit Brahma for Hetero Labs Ltd.,Hetero Labs Ltd., Unit-V,and Hetero USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 01/30/2024) (0)
Jan 29, 2024 21 MOTION for Pro Hac Vice Appearance of Attorney Timothy P. Heaton - filed by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc.. (Capuzzi, Kevin) (Entered: 01/29/2024) (4)
Jan 29, 2024 22 Pro Hac Vice Fee - Credit Card Payment received for Charanjit Brahma, Michael S. Weinstein, Timothy P. Heaton, Samuel J. Ruggio, and Hayk Snkhchyan. ( re 18 MOTION for Pro Hac Vice Appearance of Attorney Hayk Snkhchyan, 19 MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein, 20 MOTION for Pro Hac Vice Appearance of Attorney Samuel J. Ruggio, 17 MOTION for Pro Hac Vice Appearance of Attorney Charanjit Brahma, 21 MOTION for Pro Hac Vice Appearance of Attorney Timothy P. Heaton )( Payment of $ 250, receipt number ADEDC-4324882).(Capuzzi, Kevin) (Entered: 01/29/2024) (0)
Jan 29, 2024 N/A SO ORDERED, re 17 Motion for Pro Hac Vice Appearance of Attorney Charanjit Brahma; 18 Motion for Pro Hac Vice Appearance of Attorney Hayk Snkhchyan; 19 Motion for Pro Hac Vice Appearance of Attorney Michael S. Weinstein; 20 Motion for Pro Hac Vice Appearance of Attorney Samuel J. Ruggio; and 21 Motion for Pro Hac Vice Appearance of Attorney Timothy P. Heaton filed by Hetero USA Inc., Hetero Labs Ltd., Unit-V, Hetero Labs Ltd. Ordered by Judge Jennifer L. Hall on 1/29/2024. (ceg) (Entered: 01/29/2024) (0)
Jan 29, 2024 20 MOTION for Pro Hac Vice Appearance of Attorney Samuel J. Ruggio - filed by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc.. (Capuzzi, Kevin) (Entered: 01/29/2024) (4)
Jan 29, 2024 19 MOTION for Pro Hac Vice Appearance of Attorney Michael S. Weinstein - filed by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc.. (Capuzzi, Kevin) (Entered: 01/29/2024) (4)
Jan 29, 2024 18 MOTION for Pro Hac Vice Appearance of Attorney Hayk Snkhchyan - filed by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc.. (Capuzzi, Kevin) (Entered: 01/29/2024) (4)
Jan 29, 2024 17 MOTION for Pro Hac Vice Appearance of Attorney Charanjit Brahma - filed by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc.. (Capuzzi, Kevin) (Entered: 01/29/2024) (4)
Jan 29, 2024 16 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Labs Ltd., Corporate Parent Hetero Drugs Ltd. for Hetero USA Inc. filed by Hetero Labs Ltd., Hetero Labs Ltd., Unit-V, Hetero USA Inc.. (Capuzzi, Kevin) (Entered: 01/29/2024) (3)
Jan 29, 2024 15 ANSWER to 1 Complaint, , COUNTERCLAIM against All Plaintiffs by Hetero Labs Ltd., Unit-V, Hetero Labs Ltd., Hetero USA Inc..(Capuzzi, Kevin) (Entered: 01/29/2024) (30)
Jan 29, 2024 14 NOTICE of Appearance by Kevin M. Capuzzi on behalf of All Defendants (Capuzzi, Kevin) (Entered: 01/29/2024) (1)
Jan 16, 2024 N/A SO ORDERED, re 12 Motion for Pro Hac Vice Appearance of Attorney Dov P. Grossman, Shaun P. Mahaffy, Arthur J. Argall III, and Christian J. Gladden-Sorensen filed by Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC, Bayer Consumer Care AG, Orion Corporation. Ordered by Judge Jennifer L. Hall on 1/16/2024. (ceg) (Entered: 01/16/2024) (0)
Jan 16, 2024 13 Pro Hac Vice Fee - Credit Card Payment received for Dov P. Grossman, Shaun P. Mahaffy, Arthur J. Argall III, and Christian J. Gladden-Sorensen. ( re 12 MOTION for Pro Hac Vice Appearance of Attorney Dov P. Grossman, Shaun P. Mahaffy, Arthur J. Argall III, and Christian J. Gladden-Sorensen )( Payment of $ 200, receipt number ADEDC-4315477).(Fahnestock, Derek) (Entered: 01/16/2024) (0)
Jan 16, 2024 12 MOTION for Pro Hac Vice Appearance of Attorney Dov P. Grossman, Shaun P. Mahaffy, Arthur J. Argall III, and Christian J. Gladden-Sorensen - filed by Bayer Consumer Care AG, Bayer HealthCare LLC, Bayer HealthCare Pharmaceuticals Inc., Orion Corporation. (Fahnestock, Derek) (Entered: 01/16/2024) (6)
Jan 12, 2024 N/A Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (rjb) (Entered: 01/12/2024) (0)
Nov 14, 2023 11 WAIVER OF SERVICE returned executed by Orion Corporation, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC, Bayer Consumer Care AG: For Hetero USA Inc. waiver sent on 10/31/2023, answer due 1/29/2024. (Fahnestock, Derek) (Entered: 11/14/2023) (1)
Nov 14, 2023 10 WAIVER OF SERVICE returned executed by Orion Corporation, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC, Bayer Consumer Care AG: For Hetero Labs Ltd., Unit-V waiver sent on 10/31/2023, answer due 1/29/2024. (Fahnestock, Derek) (Entered: 11/14/2023) (1)
Nov 14, 2023 9 WAIVER OF SERVICE returned executed by Orion Corporation, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC, Bayer Consumer Care AG: For Hetero Labs Ltd. waiver sent on 10/31/2023, answer due 1/29/2024. (Fahnestock, Derek) (Entered: 11/14/2023) (1)
Nov 1, 2023 8 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 11/01/2023) (2)
Nov 1, 2023 N/A Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) (Entered: 11/01/2023) (0)
Oct 26, 2023 7 Summons Issued as to Hetero Labs Ltd. on 10/26/2023; Hetero Labs Ltd., Unit-V on 10/26/2023; and Hetero USA Inc. on 10/26/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mkr) (Entered: 10/27/2023) (0)
Oct 26, 2023 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG, for Bayer Consumer Care AG, Bayer HealthCare Pharmaceuticals Inc., and Bayer HealthCare LLC filed by Bayer Consumer Care AG, Bayer HealthCare Pharmaceuticals Inc., and Bayer Healthcare LLC. (mkr) (Entered: 10/27/2023) (1)
Oct 26, 2023 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Orion Corporation. (mkr) (Entered: 10/27/2023) (1)
Oct 26, 2023 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,010,530 B2; 10,383,853 B2; 10,835,515 B2; 11,168,058 B2. (mkr) (Entered: 10/27/2023) (1)
Oct 26, 2023 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about September 12, 2023. Date of Expiration of Patent: U.S. Patent No. 10,010,530 expires on 01/28/2036; U.S. Patent No. 10,383,853 expires on 01/28/2036; U.S. Patent No. 10,835,515 expires on 01/28/2036; and U.S. Patent No. 11,168,058 expires on 02/27/2038.Thirty Month Stay Deadline: on or about January 30, 2027. (mkr) (Entered: 10/27/2023) (1)
Oct 26, 2023 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 10/27/2023) (3)
Oct 26, 2023 1 Complaint* (1)
Menu